Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.
Vitamin d and multiple sclerosis.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
Voltage-gated potassium channel antibodies: Game over.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Multiple sclerosis care in Latin America.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
Molecular pathogenesis of neuromyelitis optica.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
The multiple sclerosis depression rating scale.
Rituximab combination therapy in relapsing multiple sclerosis.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
Color blindness among multiple sclerosis patients in Isfahan.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer.
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
Nature plus nurture: the triggering of multiple sclerosis.
Pages
« first
‹ previous
…
300
301
302
303
304
305
306
307
308
…
next ›
last »